您当前的位置:首页 > 主题内容 > 临床麻醉 > 专家评述

异丙酚对老年患者瑞芬太尼靶控输注效能的影响

时间:2010-08-24 09:08:42  来源:  作者:

[摘要]  目的  评价瑞芬太尼Minto药代动力学参数靶控输注(TCI)的效能,并探讨异丙酚持续静脉泵注对老年患者瑞芬太尼靶控输注效能的影响。方法  30例择期手术老年患者,ASAⅠ或II级,年龄6575岁,体重5071㎏,随机分为R组和RP组。两组都给予瑞芬太尼(血浆靶浓度5ng·ml-1)靶控输注30min;RP组在瑞芬太尼TCI同时复合异丙酚(5mg·kg-1·h-1)持续静脉泵注。实验过程中维持瑞芬太尼的靶浓度和异丙酚的输注速率不变。桡动脉穿刺进行BP监测和采集血样,锁骨下静脉穿刺进行药品和液体输注。实验过程中连续监测BIS值、MAPHRSpO2 TCI开始后1351015202530min采集桡动脉血,用高效液相色谱法测定瑞芬太尼血浆药物浓度。计算执行误差(PE)PE的中位数(MDPE)PE绝对值的中位数(MDAPE)及摆动度来评价TCI系统的性能。结果 RMDPEMDAPEWobble分别为 -16.8%、23.9%和11.3%;RP组病人的MDPEMDAPEWobble分别为-15.5%、21.7%和10.7%,组间比较差异无统计学意义(P>0.05)。两组瑞芬太尼血药浓度组内及组间比较差异无统计学意义(P>0.05);与靶浓度相比,两组瑞芬太尼实测血药浓度均显著降低(P<0.05)。结论  瑞芬太尼TCI系统(Minto药代参数)用于国人老年患者可满足临床要求,异丙酚(5mg·kg-1·h-1)持续泵注对瑞芬太尼TCI系统效能无影响。

[关键词] 二异丙酚;哌啶类;老年人;药物释放系统  

The influence of Propofol on the effect of target controlld remifentanil infusion in elderly patients

ZHANG Wei,LI Zhi-SongZHANG Si,et al. Department of Anesthesiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou  450052, China

Abstract  Objective   To evalutate the performance of the target controlled infusionTCIsystem of remifentanil using pharmacokinetic parameters reported by Minto for Chinese old patients and investigate the influence of continuos propofol infusion on TCI of remifentanil.Methods thirty ASAorpatients aged 6575yr, weighted 5071kg,undergoing surgery were included in this study.they were randomly divided into group R and RP. remifentanil (plasma concentration) 5ng·ml-1 was given by TCI in each group and propofol 5mg·kg-1·h-1was continous infused in group RP simultaneously. Remifentanil plasma target concentration and propofol infusion rate were not changed during experiment.radial atery was cannulated for BP monitoring and blood sampling.subclavian vein was cannulated for drug and fluid administration.BIS,MAP,HR and SPO2 were continuosly monitored during the experiment. Arterial blood samples were taken at 1351015202530min after TCI for determination of actual blood concentration of remifentanil by High Performance Liquid ChromarographyWaters600. The performance error(PE) was caculated for each measured blood remifentanil concentration. The performance were caculated by the median performance errorMDPE),the median absolute performance errorMDAPEand wobble(the median absolute deviation of each PE from the MDPE). Results  The MDPE,MDAPE and Wobble of the remifentanil TCI device in elderly patientsparameter described by Minto were -16.8% 、23.9 and 11.3 in group R -15.5%、21.7and 10.7 in group RP expectivelyThere were no significant diferences between the two groupsP>0.05; The measured remifentanil concentrations were no significant diferences within and between the two groupsP>0.05.Compaired with predicted target remifentanil concentration ,the measured concentrations of remifentanil were significantly lower in the two groups P<0.05. Conclusion  The  performance of Minto parameters is clinically acceptable in Chinese elderly patients;Propofol5mg·kg-1·h-1doesn’t have an influence on the remifentanil TCI system.

key wordsPropofol ;Piperidines; Aged; Drug delivery system; System performance

 

近年来,瑞芬太尼靶控输注(TCI)技术已广泛用于临床麻醉,国内瑞芬太尼TCI系统常采用西方人群瑞芬太尼Minto群体药代动力学参数,用于国人老年患者其TCI系统的效能有待进一步评价。异丙酚和哌啶类麻醉性镇痛药是常用的药物组合,研究表明异丙酚和瑞芬太尼药代动力学存在相互作用[1],异丙酚对老年患者瑞芬太尼靶控系统的效能有无影响,尚不清楚。本研究拟评价瑞芬太尼Minto药代动力学参数用于老年患者TCI系统的准确性,并探讨异丙酚静脉泵入对老年患者瑞芬太尼TCI系统效能的影响,为老年患者瑞芬太尼TCI的合理应用提供理论依据。

资料与方法

病例选择及分组 老年择期手术患者30例,ASAⅠ或Ⅱ级,年龄65~75岁,体重50~71kg,体重均在标准体重〔标准体重(kg=身高(cm)-100〕的±15以内。随机分为R组和RP,15例。无严重心肺疾患病史和肝、肾及凝血功能障碍。本研究得到医院伦理委员会同意和患者本人同意并签字。

试验方法  所有患者均未用术前药,病人入室后局麻下右锁骨下静脉穿刺,置入双腔导管,用于药物持续泵注和/或靶控输注,局麻下桡动脉穿刺置管,开放内踝静脉后于试验开始前30min内输入林格氏液10ml·kg-1, 之后按4-2-1法则持续输注。瑞芬太尼(批号:050401, 湖北宜昌人福药业有限责任公司)血浆靶浓度设定为5ng·ml-1R组病人用TCI-Ⅰ型泵(北京思路高科技发展有限公司,瑞芬太尼M into模块)靶控输注瑞芬太尼30min RP组病人瑞芬太尼靶控输注同时以5mg·kg-1·h-1的速率持续泵入异丙酚(批号:BF477,  AstraZeneca公司,英国)30min。连续监测BISMAPHRSpO2,面罩辅助呼吸使SpO2不低于90%。

瑞芬太尼血药浓度测定  TCI开始后1351015202530min分别采集桡动脉血2ml,加入50%枸橼酸40μl,转入肝素抗凝试管,置于-70冰箱保存。采用Waters 600HPLC配二极管阵列紫外检测器(Waters公司,美国 )测定瑞芬太尼血浆浓度,应用内标法测定瑞芬太尼血药浓度,检测方法见文献[2]

TCI系统性能的评价   用执行误差(PE) 、偏离度[以中位数执行误差(MDPE)来表示]、精确度[以中位数执行误差绝对值(MDAPE)来表示]、摆动度(Wobble)评估瑞芬太尼TCI系统性能。计算公式: PE%=(Cm­Cp)/Cp×100MDPE=M{PEijj=1,Ni}MDAPE=M{|PE|ij j=1,,Ni}Wobble = M {|PEijMDPEij|,j=1,…,Ni}

统计学处理 采用SPSS12.0软件进行统计分析,非正态分布的计量资料以中位数(10%分位数,90%分位数)[M (X10,X90)]表示,采用Kruskal-Wallis H检验;计量资料以均数±标准差(

R组比较,*P<0.05  TCI1min比较,#P<0.05

 

3 两组病人瑞芬太尼TCI系统性能指标[%, n=15M (X10%, X90)

4 两组病人TCI后各时点血药浓度的比较(ng·ml-1n=15,

Hoymork[11]研究异丙酚和瑞芬太尼复合TCI给药时,发现实测血药浓度与靶浓度相差很大,执行误差瑞芬太尼为22%,异丙酚为49%,认为瑞芬太尼与异丙酚在药代动力学水平可能有相互作用。Crankshaw[12]研究异丙酚靶控输注对瑞芬太尼药物浓度的影响时发现,瑞芬太尼曲线下面积(AUC),在联合用药组较单独用药组浓度增高。本研究结果表明,异丙酚5mg·kg-1·h-1持续泵注对瑞芬太尼血药浓度无影响,可能与本研究选用的瑞芬太尼剂量较小有关,Crankshaw[2]选用的瑞芬太尼输注剂量较大(250ng·LBM-1·min-1)。

瑞芬太尼靶控输注中实测血药浓度与血浆靶浓度的差异,因选用的药代动力学参数不同研究结果各异。耿志宇等[13]采用Smet参数施行TCI,发现瑞芬太尼实测血药浓度低于靶浓度,但Lang[14]采用Glaxo Wellcome参数,发现瑞芬太尼实测浓度高于靶浓度。本研究结果显示,老年患者瑞芬太尼TCIMinto药代动力学参数)时,无论单独用药还是复合用药,其实测血药浓度都低于靶浓度,张加强[7]、金树安[8]Mertens[6]的研究结果与本研究一致,提示临床上老年患者应用瑞芬太尼Minto药代参数进行TCI时,应注意实际血药浓度比血浆靶浓度低的问题。

综上所述,瑞芬太尼Minto参数TCI系统用于老年患者可满足临床要求,异丙酚(5mg·kg-1·h-1)持续泵注对瑞芬太尼TCI系统的效能无影响。

参 考 文 献

1  Bouillon T, Bruhn J, Radu-Radulescu L,et al.Non-steady state analysis of the pharmacokinetic interaction between propofol and remifentanil. Anesthesiology,2002,97:1350–1362.

2 单国瑾,吴新民,贡素宣,等. 高效液相色谱法测定人全血中瑞芬太尼浓度.中国医院药学杂志,2004,24:67-68.

3  Bjorksten AR, Chan C, Crankshaw DP. Determination of remifentanil in human blood by capillary gas chromatography with nitrogen-selective detection.
J Chromatogr B Analyt Technol Biomed Life Sci
2002,775:97-101.

4 Minto CF, Schnider TW, Egan TD, et al.Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology1997 ,86:10-23.

5  Dover DR ,Lemmens HJ. Population pharmacodynamics and pharmacokinetics of remifentanil as a supplement to nitrous oxide anesthesia for elective abdominal surgery.
Anesthesiology
1998,89:869-877.

6   MertenMJ,EngbersFH,BurmAGet al. Predictiveperformanceof computer-controlled infusion of remifentanil during propofol/remifentanil anaesthesia. Br J Anaesth2003,90:132-141.

7 张加强,邢玉英,杜文力,.瑞芬太尼靶控输注时靶浓度和实测血药浓度的差异及思路高TCI-型靶控输注系统的性能评价.中华麻醉学杂志,2005,9

8 金树安,类维富.长时间靶控麻醉瑞芬太尼实测浓度和预测浓度差值分析系统功能评价.山东大学硕士论文,2005,4

9 Minto CF, Schnider TW, Egan TD, et al.Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology1997 ,86:10-23.

10  Egan TD, Huizinga B, Gupta SK, et al.Remifentanil pharmacokinetics in obese versus lean patients.Anesthesiology,1998,89:562-73.

11  Hoymork SC,Reder J ,Grmsmo B ,etal.Bispectral index,predicted and measured drug level of target controlled infusions of remifentanil and propofol during laparoscopic cholecystectomy and emergenced . Acta Anaesth Scand,2000,44:1138-1144.

12  Crankshaw DP, Chan C, Leslie K, et al. Remifentanil concentration during target-controlled infusion of propofol.Anaesth Intensive Care,2002,30:578-583.

13 耿志宇,单国瑾,宋琳琳,等.瑞芬太尼普鲁泊福靶控输注静脉麻醉用于腹腔镜胆囊切除术.北京大学学报(医学版),2003,35:549-552.

14 Lang E, Kaplia A, Shlugman D, et al. Reduction of isoflurane minimal alveolar concentration by remifentanil.Anesthesiology,1996,85:721-728.

 

来顶一下
返回首页
返回首页

本周热点文章

站内搜索: 高级搜索
关于我们 | 主编信箱 | 广告查询 | 联系我们 | 网站地图 |